Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Abirami Subramaniam"'
Autor:
Ruaidhri J. Keane, Abirami Subramaniam, Chithra Varghese, Michael Jeffers, Seamas C. Donnelly
Publikováno v:
Respiratory Medicine Case Reports, Vol 31, Iss , Pp 101280- (2020)
Pulmonary Langerhans cell histiocytosis (PLCH) is a rare cystic lung disease. The natural history is often unpredictable making it difficult to diagnose. We report a 63-year-old male with dyspnoea, chronic cough and recurrent respiratory tract infect
Externí odkaz:
https://doaj.org/article/6cb0f14fad76456799bfbbe96106c70d
Autor:
Dmitry Kudlay, Igor Kaidashev, Line Tannert, Gabrielle Laura Onorato, Abirami Subramaniam, Rudolf Valenta, Jaime Correia de Sousa, Holger Schünemann, Lorenzo Cecchi, Anke Maitland-van der Zee, Ana Margarida Pereira, George Christoff, Nombeko Monica Mashiya, Klaus F. Rabe, Luís Midão, Linda Cox, Jeroen Buters, Frederico Regateiro, Jean Bousquet, Mona Al-Ahmad, Sergio Bonini, Peter Howarth, Filip Raciborski, Gerard Dray, Luo Zhang, Didier EBO, Adnan Custovic, Elham Hossny, Ratko Djukanovic, Violeta Kvedarienė, Heather Zar, Alessandro Fiocchi, Chris Brightling, Cem Meco, Sietze Reitsma, Derek Chu, Ian Adcock, Olga Lourenço
Publikováno v:
Bousquet, Jean; Anto, Josep M; Iaccarino, Guido; Czarlewski, Wienczyslawa; Haahtela, Tari; Anto, Aram; Akdis, Cezmi A; Blain, Hubert; Walter Canonica, G; Cardona, Victoria; Cruz, Alvaro A; Illario, Maddalena; Ivancevich, Juan Carlos; Jutel, Marek; Klimek, Ludger; Kuna, Piotr; Laune, Daniel; Larenas-Linnemann, Désirée; Mullol, Joaquim; Papadopoulos, Nikos G; ... (2020). Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? Clinical and translational allergy, 10(44), p. 44. BioMed Central 10.1186/s13601-020-00351-w
Clinical and Translational Allergy, Vol 10, Iss 1, Pp 1-3 (2020)
Clinical and translational allergy, Vol. 10, p. 44 (2020)
Clinical and Translational Allergy
Clinical and Translational Allergy, Vol 10, Iss 1, Pp 1-3 (2020)
Clinical and translational allergy, Vol. 10, p. 44 (2020)
Clinical and Translational Allergy
Reported COVID-19 deaths in Germany are relatively low as compared to many European countries. Among the several explanations proposed, an early and large testing of the population was put forward. Most current debates on COVID-19 focus on the differ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fd85c1735b519e804aff5705a429505
https://doi.org/10.5167/uzh-195115
https://doi.org/10.5167/uzh-195115
Publikováno v:
Airway pharmacology and treatment.
Introduction: Reslizumab, a humanised monoclonal antibody against interleukin-5, has been demonstrated in clinical trials to be an effective add-on treatment for adult patients with SEA (Castro M et al. Lancet Respir Med 2015;3:355–66). To date, th
Autor:
Abirami Subramaniam, Barry J. Plant, Michael T. Henry, N.J. Ronan, Kashif Ali Khan, Louise M. Burke, Adeline Chelliah, Yvonne McCarthy
Publikováno v:
1.5 Diffuse Parenchymal Lung Disease.
Objectives: IPF is a progressive fibro-proliferative lung disease that causes destruction of lung architecture. Pirfenidone is the first licensed therapy for IPF. The aim of this prospective study is to characterise specific molecular and cellular me
Publikováno v:
1.2 Rehabilitation and Chronic Care.
The prevalence of COPD in Ireland is about 400,000 and is the third most common cause of death worldwide. Pulmonary rehabilitation (PR) has been proven to be effective in optimising functional status and improving health-related quality of life in CO
Autor:
Barry J. Plant, Michael Henry, Mohamed Elshafi, Louise M. Burke, Joanne P. O’Donovan, Abirami Subramaniam, Desmond M. Murphy, Marcus P. Kennedy, Kashif Ali Khan
Publikováno v:
1.5 Diffuse Parenchymal Lung Disease.
Introduction: In Interstitial lung disease (ILD), when an aetiological factor is absent and clinical-radiological identification is non-contributory, histology is required in the form of surgical lung biopsy (SLB). SLB is not without risk. Cryotechni
Autor:
Michael Henry, Mohamed Elshafi, Abirami Subramaniam, Bernadette Bowen, Kate O'Halloran, Kashif Ali Khan, Desmond M. Murphy, Barry J. Plant, Marcus P. Kennedy, Loraine Thong
Publikováno v:
1.5 Diffuse Parenchymal Lung Disease.
Background: Pirfenidone is the first therapy for idiopathic pulmonary fibrosis (IPF) that alters the natural progression of the disease. We report our experience thus far, on Pirfenidone use at a specialist interstitial lung disease clinic in Ireland
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::25448a40eb58a3ed3f799a8315bc6f16
http://www.scopus.com/inward/record.url?eid=2-s2.0-84877275591&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84877275591&partnerID=MN8TOARS
Publikováno v:
Irish Journal of Medical Science; 2023 Suppl2, Vol. 192, p41-120, 80p
Autor:
Bousquet, Jean1,2,3,4 (AUTHOR) jean.bousquet@orange.fr, Anto, Josep M.5,6,7,8 (AUTHOR), Iaccarino, Guido9 (AUTHOR), Czarlewski, Wienczyslawa10,11 (AUTHOR), Haahtela, Tari12 (AUTHOR), Anto, Aram10 (AUTHOR), Akdis, Cezmi A.13 (AUTHOR), Blain, Hubert14,15 (AUTHOR), Canonica, G. Walter16 (AUTHOR), Cardona, Victoria17 (AUTHOR), Cruz, Alvaro A.18 (AUTHOR), Illario, Maddalena19,20 (AUTHOR), Ivancevich, Juan Carlos21,22 (AUTHOR), Jutel, Marek23 (AUTHOR), Klimek, Ludger24 (AUTHOR), Kuna, Piotr25 (AUTHOR), Laune, Daniel26 (AUTHOR), Larenas-Linnemann, Désirée27 (AUTHOR), Mullol, Joaquim28 (AUTHOR), Papadopoulos, Nikos G.29,30 (AUTHOR)
Publikováno v:
Clinical & Translational Allergy. 5/27/2020, Vol. 10 Issue 1, p1-7. 7p.